Abstract:Following the global-level Ebola virus disease (EVD) outbreak during 2014–2016, international collaboration with multiorganizational participation has rapidly increased. Given the greater priorities for research and development (R&D) outcomes despite the quantitative and qualitative lack of high-containment laboratory facilities in low- and middle-income countries (LMICs), where biological targets for investigation are located near their natural habitats, occupational readiness for health workers' safety has not been well-addressed, where limited global expert human resources are being deployed to high-containment laboratories including biosafety level 4 (BSL-4) facilities for case management and medical investigations. Pursuing scientific and managerial success to make laboratories efficient and productive, most laboratory safety policies have focused on the functionality of technical skills or performance, procedural methodologies, and supervision over the employees to collaborate in LMICs. The experts dispatched from advanced countries bring a long list of scientific tasks with high-tech devices, supplies, and training programs to introduce their collaboration with local partners in LMICs. However, the dispatched experts would subsequently realize their list becomes endless to establish their basic functions required in high-containment laboratories to ensure qualified scientific outcomes in LMICs. Under such circumstances where dual or multiple policies and standards accommodated pose dilemmas for operational procedures to ensure biosafety and biosecurity, all the frontline experts from both LMICs and advanced countries may be exposed to significant risks of life-threating infection of highly pathogenic agents like EVD, without any pragmatic measures or road maps to establish valued international collaboration, pursuing its sustainability. Given the fact mentioned above, we conducted a quick review of the key biosafety and biosecurity management documents, relevant policy analyses, and research to understand the current status and, if any, measures to dissolve critical dilemmas mentioned above. As a result, we found that occupational safety and health (OSH) aspects had not been sufficiently addressed, particularly in the context of international BSL-4 collaboration in LMICs. Moreover, consideration of OSH can be one of the key drivers to make such collaborative interventions more pragmatic, safer to reorient, harness disease-based vertical approaches, and harmonize policies of biosafety and biosecurity, particularly for collaborations organized in resource-limited settings.

Clinical examination and personal biosafety protection for infectious specimens with Ebola virus in biosafety level 3 laboratory

Prevention and Consideration for the Biosafety of Laboratory Testing under Epidemic Condition

The Chinese Ebola Diagnostic and Treatment Center in Liberia As a Model Center

Epstein-Barr Virus Variation in People Living with Human Immunodeficiency Virus in Southeastern China.

To Explore Biological Safety Management and Protective Measures in Clinical Laboratory of the Infectious Disease Hospital

Clinical Laboratory Biosafety Gaps: Lessons Learned from Past Outbreaks Reveal a Path to a Safer Future.

Investigation on the Medical Records Writing and Management of Patients with Ebola Virus Disease

Rapid deployment of a mobile biosafety level-3 laboratory in Sierra Leone during the 2014 Ebola virus epidemic

[Safety Surveillance and Management of Specimen Associated with SARS in Clinical Laboratory].

Establishment and implementation of laboratory biosafety record keeping and management

[Principles and Suggestions on Biosafety Protection of Biological Specimen Preservation During Prevalence of COVID-19].

Current status and future challenges of high-level biosafety laboratories in China

Laboratory biosafety in China: past, present, and future

The state of biosafety across China's CDC microbiology laboratories: insights from a nationwide survey (2021-2023)

Lessons learned: critical care management of patients with Ebola in the United States

Harmonization of Biosafety and Biosecurity Standards for High-Containment Facilities in Low- and Middle-Income Countries: An Approach From the Perspective of Occupational Safety and Health

Addressing Infection Prevention and Control in the First U.S. Community Hospital to Care for Patients With Ebola Virus Disease: Context for National Recommendations and Future Strategies

Studies on developing a safe-management standard system for Chinese biosafety laboratories

Ebola Virus Disease Diagnostics, Sierra Leone: Analysis of Real-time Reverse Transcription-Polymerase Chain Reaction Values for Clinical Blood and Oral Swab Specimens

Investigation on personnel management in biosafety level 3 laboratory

Improved Biosafety and Biosecurity Measures and/or Strategies to Tackle Laboratory-Acquired Infections and Related Risks